These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3309954)

  • 21. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Androgen receptors].
    Shimazaki J; Kodama T; Akakura K
    Nihon Rinsho; 1987 Nov; 45(11):2630-7. PubMed ID: 3444052
    [No Abstract]   [Full Text] [Related]  

  • 23. Androgen-regulated gene expression in prostate cancer.
    Trapman J; Cleutjens KB
    Semin Cancer Biol; 1997 Feb; 8(1):29-36. PubMed ID: 9299579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of androgen-independent prostate cancer.
    Feldman BJ; Feldman D
    Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New concepts in studying the control of normal and cancer growth of the prostate.
    Coffey DS; Pienta KJ
    Prog Clin Biol Res; 1987; 239():1-73. PubMed ID: 3309951
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 27. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The androgen receptor: a potential target for therapy of prostate cancer.
    Santos AF; Huang H; Tindall DJ
    Steroids; 2004 Feb; 69(2):79-85. PubMed ID: 15013685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mutated androgen receptor and its implications for the treatment of metastatic carcinoma of the prostate.
    Middleman MN; Lush RM; Figg WD
    Pharmacotherapy; 1996; 16(3):376-81. PubMed ID: 8726595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.
    McCulloch DR; Opeskin K; Thompson EW; Williams ED
    Prostate; 2005 Sep; 65(1):35-43. PubMed ID: 15800936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice.
    Ito YZ; Mashimo S; Nakazato Y; Takikawa H
    Cancer Res; 1985 Oct; 45(10):5058-63. PubMed ID: 4027985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.
    Zegarra-Moro OL; Schmidt LJ; Huang H; Tindall DJ
    Cancer Res; 2002 Feb; 62(4):1008-13. PubMed ID: 11861374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of androgen receptor signaling in prostate cancer.
    Dehm SM; Tindall DJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):63-74. PubMed ID: 15757439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The mechanism of hormone-independent recurrence of prostate cancer].
    Fukabori Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():45-52. PubMed ID: 11022683
    [No Abstract]   [Full Text] [Related]  

  • 36. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
    Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
    Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comments on an in vitro model of hormonally refractory prostate cancer.
    Joyal JL; Israel DI; Garnick MB
    Cancer J; 2000; 6(4):213-4. PubMed ID: 11038139
    [No Abstract]   [Full Text] [Related]  

  • 38. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
    Schröder FH
    Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on usefulness of the crude nuclear DHT measurement in prostatic cancer patients].
    Tohjoh S
    Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1327-35. PubMed ID: 2480469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the androgen receptor in the development and progression of prostate cancer.
    Jenster G
    Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.